Podcasts about european society

CUPOM: BLACKFRIDAYGUIA www.tadeclinicagem.com.br/guia - Conheça o Guia TdC com 7 dias grátis Um serviço de revisão e atualização continuados em clínica médica. A informação que você precisa, do jeito que você prefere. Junte-se aos mais de 800 assinantes. Assine o Guia, ganhe tempo e atualize-se sem esforço. Joanne, Kaue e Lucca conversam sobre armadilhas no tromboembolismo pulmonar (TEP): Quando pedir d-dímero e ajuste, em que momento iniciar a anticoagulação, como fazer a estratificação, quando trombolisar, qual anticoagulante iniciar, anticoagular ou não o TEP subsegmentar/assintomático e um pouco de TEP na gestante. Referências: 1. Kahn SR, de Wit K. Pulmonary Embolism. N Engl J Med. 2022 Jul 7;387(1):45-57. doi: 10.1056/NEJMcp2116489. PMID: 35793208. 2. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J 2019; 54. 3. Raja AS, Greenberg JO, Qaseem A, et al. Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 2015; 163:701. 4. Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest 2021; 160:e545. 5. Kucher N, Goldhaber SZ. Management of massive pulmonary embolism. Circulation 2005; 112:e28. 6. Aujesky D, Obrosky DS, Stone RA, et al. A prediction rule to identify low-risk patients with pulmonary embolism. Arch Intern Med 2006; 166:169. 7. Becattini C, Casazza F, Forgione C, et al. Acute pulmonary embolism: external validation of an integrated risk stratification model. Chest 2013; 144:1539. 8. Righini M, Van Es J, Den Exter PL, Roy PM, Verschuren F, Ghuysen A, Rutschmann OT, Sanchez O, Jaffrelot M, Trinh-Duc A, Le Gall C, Moustafa F, Principe A, Van Houten AA, Ten Wolde M, Douma RA, Hazelaar G, Erkens PM, Van Kralingen KW, Grootenboers MJ, Durian MF, Cheung YW, Meyer G, Bounameaux H, Huisman MV, Kamphuisen PW, Le Gal G. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014 Mar 19;311(11):1117-24. doi: 10.1001/jama.2014.2135. Erratum in: JAMA. 2014 Apr 23-30;311(16):1694. PMID: 24643601. 9. Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, Hutten BA, Jaff MR, Manja V, Schulman S, Thurston C, Vedantham S, Verhamme P, Witt DM, D Florez I, Izcovich A, Nieuwlaat R, Ross S, J Schünemann H, Wiercioch W, Zhang Y, Zhang Y. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020 Oct 13;4(19):4693-4738. doi: 10.1182/bloodadvances.2020001830. PMID: 33007077; PMCID: PMC7556153. 10. Duffett L, Castellucci LA, Forgie MA. Pulmonary embolism: update on management and controversies. BMJ. 2020 Aug 5;370:m2177. doi: 10.1136/bmj.m2177. PMID: 32759284. 11. van der Hulle T, Cheung WY, Kooij S, Beenen LFM, van Bemmel T, van Es J, Faber LM, Hazelaar GM, Heringhaus C, Hofstee H, Hovens MMC, Kaasjager KAH, van Klink RCJ, Kruip MJHA, Loeffen RF, Mairuhu ATA, Middeldorp S, Nijkeuter M, van der Pol LM, Schol-Gelok S, Ten Wolde M, Klok FA, Huisman MV; YEARS study group. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet. 2017 Jul 15;390(10091):289-297. doi: 10.1016/S0140-6736(17)30885-1. Epub 2017 May 23. Erratum in: Lancet. 2017 Jul 15;390(10091):230. PMID: 28549662.

Today my guest is Pathologist Dr Aleš Ryška What we discuss with Dr Ryška: Why he decided to go to medical school and how he discovered pathology His thoughts on why students are not choosing medicine as a career, and what to do about that How he got involved in the Czech Society of Pathology and the European Society of Pathology his role as current President of the ESP The recent European Congress of Pathology and why it was a hybrid format for the first time The state of molecular pathology in Europe Multidisciplinary Molecular Tumor Boards, and the role the Pathologist should have in molecular testing Links for this episode: Health Podcast Network  LabVine Learning The ConfLab from LabVine Dress A Med scrubs   European Society of Pathology Czech Society of Pathology NSCLC molecular testing in Central and Eastern European countries The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology   People of Pathology Podcast: Website Instagram Twitter

In this World Shared Practice Forum podcast, Dr. Robert Tasker discusses trends in research over the past year from his position as Editor-in-Chief of the Pediatric Critical Care Medicine Journal. Dr. Tasker shares his views on some of the most active areas of research in the field of pediatric critical care medicine in 2022 and provides an insider's look at many metrics relating to the PCCM Journal itself, including impact factors, subscribership numbers, and Altmetric scores. Upon listening to this presentation, learners should be able to: -Identify diverse areas of active research interest within the field of pediatric critical care medicine -Describe the reach and impact of the journal Pediatric Critical Care Medicine within the field of pediatrics, and within medicine more generally -Interpret Altmetric scores to better understand the global reach of a published work Publication date: November 18, 2022. Citation: Tasker R, Daniel D, Burns JP. Research Trends in Pediatric Critical Care Medicine: Editor's Perspective. 11/2022. Online Podcast. OPENPediatrics. https://youtu.be/EnOz15CTiEI. Articles referenced: Jonat B, Gorelik M, Boneparth A, et al. Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019 in a Children's Hospital in New York City: Patient Characteristics and an Institutional Protocol for Evaluation, Management, and Follow-Up. Pediatr Crit Care Med. 2021;22(3):e178-e191. (11:39) Capasso L, De Bernardo M, Vitiello L, Rosa N. Ultrasound Options for Measuring Optic Nerve Sheath Diameter in Children. Pediatr Crit Care Med. 2021;22(5):e329-e330. (12:40) Staveski SL, Pickler RH, Khoury PR, et al. Prevalence of ICU Delirium in Postoperative Pediatric Cardiac Surgery Patients. Pediatr Crit Care Med. 2021;22(1):68-78. (13:42) Ozment CP, Scott BL, Bembea MM, Spinella PC; Pediatric ECMO (PediECMO) subgroup of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network and the Extracorporeal Life Support Organization (ELSO). Anticoagulation and Transfusion Management During Neonatal and Pediatric Extracorporeal Membrane Oxygenation: A Survey of Medical Directors in the United States. Pediatr Crit Care Med. 2021;22(6):530-541 (14:05) Rimensberger PC, Kneyber MCJ, Deep A, et al. Caring for Critically Ill Children With Suspected or Proven Coronavirus Disease 2019 Infection: Recommendations by the Scientific Sections' Collaborative of the European Society of Pediatric and Neonatal Intensive Care. Pediatr Crit Care Med. 2021;22(1):56-67. (14:47) Additional references: Pediatric Critical Care Medicine journal: https://journals.lww.com/pccmjournal (06:42) Pediatric Critical Care section of Frontiers in Pediatrics journal: https://www.frontiersin.org/journals/pediatrics/sections/pediatric-critical-care (06:59) Journal of Pediatric Critical Care: https://www.jpcc.org.in (07:06) Critical Care Medicine journal: https://journals.lww.com/ccmjournal/pages/default.aspx (07:20) Pediatric Pulmonology journal: https://onlinelibrary.wiley.com/journal/10990496 (07:28) Atlmetric: https://www.altmetric.com/ (16:42) Please visit: http://www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open-access and thus at no expense to the user. For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu

In this episode, we explore the role of vascular surgeons in oncologic surgery. We will be discussing the nuances of vascular involvement in oncologic resection, common practices, and future directions of this collaborative surgical culture.   Dr. Adam Beck (@AWBeckMD) is a vascular surgeon and Professor of Surgery at the University of Alabama at Birmingham where he serves as the Director of the Division of Vascular Surgery and Endovascular Therapy, holds the Holt A. McDowell, Jr, MD Endowed Chair in Vascular Surgery and serves as the Director of Quality and Associate Chief Medical Quality Officer for the UAB Cardiovascular Institute. Dr. Beck completed his general surgery residency training and a surgical oncology research fellowship at the University of Texas-Southwestern Medical Center. He trained in vascular surgery at the Dartmouth-Hitchcock Medical Center and then completed a fellowship in advanced endovascular techniques, including branched and fenestrated endografts for aortic aneurysmal disease, at the University Medical Center of Groningen in The Netherlands. You can learn more about Dr. Adam Beck here.   Dr. Xavier Berard (@XavierBerardMD)  is a French vascular surgeon and serves as a Consultant in the Department of Vascular Surgery and Professor of Vascular and Endovascular Surgery in Bordeaux University Hospital in Bordeaux, France. He is board certified from the French College of Vascular and Endovascular Surgeons and from the European Society for Vascular and Endovascular Surgery. He has also completed a PhD in Vascular Biomaterials and has built a library of educational video content. He works closely with Institut Bergonié Bordeaux Cancer Center for sarcomas. You can see educational videos and learn more about Dr. Xavier Berard here   Dr. Sharif Ellozy (@SharifEllozy)  is a vascular surgeon at the New York-Presbyterian/Weill Cornell Medical Center where he serves as Associate Professor of Clinical Surgery in the Division of Vascular and Endovascular Surgery, and Program Director of the Vascular Surgery Fellowship program. He is also one of the founders of Audible Bleeding. He is readily involved in oncologic resection at the Memorial Sloan Kettering Cancer Center and works closely with surgical oncologists on operative cases that have vessel involvement.   Authors/Interviewers: Dr. Sree Kanna, MD - McGill, Montreal (@VulnerableAorta) Dr. Nakia Sarad, DO, MS - New York-Presbyterian/Queens - Weill Cornell, New York (@NakSaradDO)   Editors: Morgan Gold, MD,CM candidate - McGill, Montreal (@MorganSGold) Ezra Schwartz, MD,CM, MS, MMSc-Med Ed candidate - Harvard, Boston (@EzraSchwartz10)   Helpful Resources:   To learn more about sarcoma resections, check out the Schwarzbach papers on lower extremity sarcomas and retroperitoneal sarcomas   Click here to learn more about the NCCN Guidelines on Resectability of Pancreatic Cancers   Click here to learn more about IVC Reconstruction Techniques in Oncologic Surgery   Video of IVC Leiomyosarcoma Reconstructions here (courtesy of Dr. Berard)   Click here to learn more about the Renal Cell Carcinoma Mayo Staging System Click here to find the original article on the Shamblin Classification for Carotid Body Tumors   Check out this review paper on Oncovascular Surgery    Check out this paper on spiral endografts here Video of spiral saphenous vein graft technique here (courtesy of Dr. Berard)   What other topics would you like to hear about? Let us know more about you and what you think of our podcast through our Listener Survey or email us at AudibleBleeding@vascularsociety.org. Follow us on Twitter @audiblebleeding   Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.  

Welcome back to the podcast and to November's Papers Of The Month. First up we're taking a look at a paper that challenges the current American Heart Association (AHA) and European Society of Cardiology (ESC) guidelines that recommend when right ventricular myocardial infarction, that patients are not administered nitrates due to the risks of compromise of cardiac output.  Secondly we look at an RCT, with some really clever blinding, that looks at different BP targets for intubated and ventilated patients in ICU who have sustained a cardiac arrest. Finally we take a look at a paper focussing on healthcare professionals' perceptions  of interprofessional teamwork in the emergency critical incidents. Once again we'd love to hear any thoughts or feedback either on the website or via twitter @TheResusRoom. Simon & Rob

From the European Society for Clinical Virology 2022 Conference in Manchester UK, Vincent speaks with Richard Knight about prion diseases and the outbreak of bovine spongiform encephalitis that led to cases of variant Creutzfeldt-Jakob disease in humans. Host: Vincent Racaniello Guest: Richard Knight Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode National CJD Research and Surveillance Unit Clinical diagnosis of human prion disease (Prog Mol Biol Trans Sci) Variant Creutzfeldt-Jakob disease (Handbook Clin Viral) Creutzfeldt-Jakob disease (Adv Exp Med Biol) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

Conversation starts @ 5:47 Hermes Trismegistus was believed to be one of the wise men of his time, and a study of his texts reveals, not a general philosophy, but a spiritual path for initiates who seek to achieve gnosis by direct acquaintance of the true nature of reality as we experience it. Dr. Wouter Hanegraaff begins this analysis by guiding us into the four-core dimension of his book, Hermeticism, spirituality, historical imagination, and altered states of knowledge. All of this knowledge circulated through small groups of people beginning in the first century A.D. Wouter explains how he landed a position as The University of Amsterdam chair of Hermeticism, and then began to “map” the field of esoterism, the two poles of his academic interests are Hermeticism and esotericism. We discuss the nature of esotericism, rejected forms of knowledge, monotheism and exclusion, the shadow of the collective, Isaac Newton's heresy, Western exclusion, nonduality, the experiential nature of spiritual practice, Diotima - the female visionary who taught Socrates, drugs in the ancient world, The East and the irrational, academic ideological orientation to Greek as rational, misunderstanding and misinterpretation of antiquity, gender, the spiritual nature of rebirth, life and death, immortality and “The Flip,” shoutout to Miles Neale and Jeff Kripal, music and the cosmos, tones and chanting, initiation, apprenticeship, magic, therapy, and more. Bio: Wouter J. Hanegraaff is Professor of History of Hermetic Philosophy and Related Currents at the University of Amsterdam, the Netherlands, a member of the Royal Dutch Academy of Arts and Sciences, as well as past President and now honorary member of the European Society for the Study of Western Esotericism. Alongside numerous articles, he is the author of New Age Religion and Western Culture: Esotericism in the Mirror of Secular Thought (Leiden 1996/Albany 1998); Lodovico Lazzarelli (1447-1500): The Hermetic Writings and Related Documents (Tempe 2005; with Ruud M. Bouthoorn); Swedenborg, Oetinger, Kant: Three Perspectives on the Secrets of Heaven (West Chester 2007); Esotericism and the Academy: Rejected Knowledge in Western Culture (Cambridge 2012); and Western Esotericism: A Guide for the Perplexed (London 2013). He has (co)edited eight collective volumes, including the 1200-page Dictionary of Gnosis and Western Esotericism (Leiden 2005) and Hidden Intercourse: Eros and Sexuality in the History of Western Esotericism (New York 2011; with Jeffrey J. Kripal). His most recent monograph Hermetic Spirituality and the Historical Imagination: Altered States of Knowledge in Late Antiquity is forthcoming with Cambridge University Press in 2022. His current projects are focused on the history of consciousness in German Idealism and Romanticism, and the role of the imagination in Western culture. https://www.wouterjhanegraaff.net Website for The Sacred Speaks: http://www.thesacredspeaks.com WATCH: YouTube for The Sacred Speaks https://www.youtube.com/channel/UCOAuksnpfht1udHWUVEO7Rg Instagram: https://www.instagram.com/thesacredspeaks/ @thesacredspeaks Twitter: https://twitter.com/thesacredspeaks Facebook: https://www.facebook.com/thesacredspeaks/ Brought to you by: https://www.thecenterforhas.com Theme music provided by: http://www.modernnationsmusic.com

Doctors Lisa and Sara speak with GP Dr Uma Marthi about Endometriosis; a topic she is passionate about due to the common delay in diagnosis, coupled with the impact this condition has on peoples' lives.  We talk through a hypothetical case and explore differential diagnoses for dysmenorrhoea, examination tips, investigations and management. We discuss the importance and impact of this condition, fertility and the need to think about and treat this as soon as we can. You can use these podcasts as part of your CPD - we don't do certificates but they still count :) Useful resources:  NICE Clinical Knowledge Summaries, Dysmenorrhoea: https://cks.nice.org.uk/topics/dysmenorrhoea/ NICE Clinical Knowledge Summaries, Endometriosis: https://cks.nice.org.uk/topics/endometriosis/ All Parliamentary Group on Endometriosis: https://www.endometriosis-uk.org/all-party-parliamentary-group-endometriosis Endometriosis UK: https://www.endometriosis-uk.org/ European Society of Human Reproduction and Embryology Endometriosis Guidelines: https://www.eshre.eu/Guideline/Endometriosis Guardian Article: Endometriosis took my fertility, and part of my self Hilary Mantel (Sept 2015): https://www.theguardian.com/commentisfree/2015/sep/28/endometriosis-fertility-hilary-mantel All Party Parliamentary Group (APPG) on Endometriosis Inquiry Report 2020: https://www.endometriosis-uk.org/sites/default/files/files/Endometriosis%20APPG%20Report%20Oct%202020.pdf British Society for Gynecological Endoscopy, includes links to Specialist Endometriosis Centres around the UK: https://www.bsge.org.uk/ ___ We really want to make these episodes relevant and helpful: if you have any questions or want any particular areas covered then contact us on Twitter @PCKBpodcast, or leave a comment on our really quick anonymous survey here: https://pckb.org/feedback ___ This podcast has been made with the support of GP Excellence and Wigan CCG. Given that it is recorded with Greater Manchester clinicians, the information discussed may not be applicable elsewhere and it is important to consult local guidelines before making any treatment decisions.  The information presented is the personal opinion of the healthcare professional interviewed and might not be representative to all clinicians. It is based on their interpretation of current best practice and guidelines when the episode was recorded. Guidelines can change; To the best of our knowledge the information in this episode is up to date as of it's release but it is the listeners responsibility to review the information and make sure it is still up to date when they listen. Dr Lisa Adams, Dr Sara MacDermott and their interviewees are not liable for any advice, investigations, course of treatment, diagnosis or any other information, services or products listeners might pursue as a result of listening to this podcast - it is the clinicians responsibility to appraise the information given and review local and national guidelines before making treatment decisions. Reliance on information provided in this podcast is solely at the listeners risk. The podcast is designed to be used by trained healthcare professionals for education only. We do not recommend these for patients or the general public and they are not to be used as a method of diagnosis, opinion, treatment or medical advice for the general public. Do not delay seeking medical advice based on the information contained in this podcast. If you have questions regarding your health or feel you may have a medical condition then promptly seek the opinion of a trained healthcare professional.

For this episode, we have two fascinating interviews in honor of National Breast Cancer Awareness Month, when we raise awareness for the prevention, early detection, treatment, and survivorship of breast cancer. To that end, we speak with Dr. Tania Španić, President of Europa Donna, The European Breast Cancer Patient Organization, who is a survivor herself. She is also Chair of the European Society of Medical Oncology's Patient Advocacy Working Group. We also talk to Dr. Ines-Maria Vaz-Duarte-Luis from the Cancer Institute Gustave Roussy in Paris, about her recent articles on the dynamics of patient-reported outcomes after adjuvant breast cancer chemotherapy. We hope these 2 interviews provide the lens of the patient perspective and physician-researcher on various QOL aspects that patients affected by breast cancer must face. Enjoy Listening!Additional readingPaluch-Shimon S, et al. ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5). Ann Oncol. 2022 Aug 4:S0923-7534(22)01858-0. Di Meglio A, et al. Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy. J Clin Oncol. 2022 Sep 20;40(27):3190-3204. Vaz-Luis I, et al. ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe. Ann Oncol. 2022 Aug 10:S0923-7534(22)03792-9.  

This episode of the EMJ podcast explores various aspects of obstructive hypertrophic cardiomyopathy (HCM), and features expert insights from Antonis Pantazis, Consultant Cardiologist at the Royal Brompton and Harefield hospitals in London, UK, and Chairperson of the European Society of Cardiology (ESC) Working Group on Myocardial and Pericardial Diseases. This podcast was sponsored by Myokardia and Bristol Myers Squibb.

The European Society for Medical Oncology (ESMO) Annual Meeting, showcased an array of updates in breast cancer care and management,... The post Breast Cancer Sessions: Highlights from ESMO 2022 with Elisa Agostinetto & Evandro de Azambuja appeared first on VJOncology.

Live from AOSSM 2022! Jacques Menetrey, MD, PhD, Professor of Orthopaedic Surgery at the University Hospital of Geneva, Medical Director of Swiss Olympic Medical Center Hirslanden Clinique La Colline, and Past President of European Society of Sports Traumatology, Knee Surgery and Arthroscopy (ESSKA), joins Dr. Rieder to share his experience caring for ballet dancers vs hockey players, how to be a great reviewer, living in Geneva, and more.

Traumatic experiences across the lifespan often lead to long-term negative consequences on mental health. Recent studies on trauma- and stress-related disorders reveal diverse trajectories of human responses to adverse life experiences. Various mental disorders associated with stress, such as adjustment disorder, prolonged grief, or complex posttraumatic stress disorder have been studied extensively providing novel knowledge, but also opening up new issues in how to better understand, prevent and treat these conditions. The huge global burden of trauma calls for novel approaches to providing trauma treatment for those in need. The September keynote lecture will be delivered by Professor Evaldas Kazlauskas, President of the European Society for Traumatic Stress Studies and Head of the Center for Psychotraumatology at Vilnius University in Lithuania. The lecture will be followed by a panel discussion. Webinar series organized by SWPS University and the European Association of Clinical Psychology and Psychological Treatment (EACLIPT). #traumaticexperiences #psychology #EACLIPT

At the European Society for Medical Oncology Congress 2022, Dr. Matthew Goetz presented interim overall survival results from the MONARCH 3 study showing that adding Verzenio to an aromatase inhibitor improves overall survival by 12.6 months for advanced-stage, hormone receptor-positive, HER2-negative breast cancer. Listen to the podcast to hear Dr. Goetz explain: how Verzenio works the aims of MONARCH 3 study the difference between progression-free and overall survival and why each is important Verzenio side effects what the results mean for people diagnosed with advanced-stage, hormone receptor-positive, HER2-negative breast cancer

Sepsis occurs when the body's immune system responds to an infection and injures its own tissues and organs. It is a medical emergency, requiring early detection and treatment as it can lead to septic shock, multi-organ failure, and death. One in five deaths worldwide is associated with sepsis and 40% of cases are in children under five years of age. Sepsis is the number one cause of death in hospitals, the number one cause of hospital readmissions, and the number one healthcare cost. Laboratory testing is essential in helping prevent, detect, and treat sepsis to minimize injury to the body and the risk of death.   About Our Speaker:  Dr. Lui Forni is a Professor and Consultant Nephrologist and Intensivist at Royal Surrey County Hospital NHS Foundation Trust in Guildford, England. Professor Forni earned a PhD in physical chemistry and subsequently studied medicine, specializing in nephrology and intensive care medicine. His research interests include pre-operative assessment of high-risk surgical candidates, renal replacement therapy, diagnosis, pathophysiology and treatment of acute kidney injury, and predictive modeling in acute medical admissions. He lectures both nationally and internationally and has published widely.  He served as the Past Research Chair and is the Current Secretary of the European Society of Intensive Care Medicine.

A new Clinical Consensus Statement on renal denervation is hot off the press! Could your patients with hypertension benefit from renal denervation? Credit available for this activity expires: 9/27/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/981437?src=mkm_podcast_addon_981437

即刻加入15Mins通勤學英語直播室，每週一9pm等你來說英文 : https://15minsengcafe.pse.is/46hm8k 每日英語跟讀 Ep.K440: How to Get Heart Patients to Take Their Pills? Give Them Just One. Heart disease kills more people than any other condition, but despite advances in treatment and prevention, patients often do not stick to their medication regimens. Now researchers may have found a solution: a so-called polypill that combines three drugs needed to prevent cardiovascular trouble. 死於心臟病的人比死於其他任何疾病的人都多，儘管在治療和預防上取得進展，患者往往不能堅守他們的藥物治療方式。現在，研究人員可能已經找到一個解決方法：一種混合三種預防心血管疾病所需藥物的所謂複方製劑。 In what is apparently the largest and longest randomized controlled trial of this approach, patients who were prescribed a polypill within six months of a heart attack were more likely to keep taking their drugs and had significantly fewer cardiovascular events, compared with those receiving the usual assortment of pills. 在明顯是這種方法規模最大、時間最長的隨機對照試驗中，心臟病發作後6個月內服用複方製劑的患者，跟服用常規藥物患者相比，更有可能繼續服用藥物，心血管事件明顯減少。 The participants also experienced one-third fewer cardiovascular deaths, although their overall risk of death from all causes was not significantly changed. 參與者因心血管疾病死亡人數也減少三分之一，即便他們因為各種原因死亡的總體風險沒有顯著改變。 The study of more than 2,000 heart patients, who were followed for three years, was published Friday morning in The New England Journal of Medicine, as the findings were presented at the European Society of Cardiology Congress in Barcelona, Spain. 這項研究對2000多名心臟病患者進行三年追蹤調查，研究結果周五上午發表在《新英格蘭醫學雜誌》，並在西班牙巴塞隆納舉行的歐洲心臟病學會年會上發表。 The study is the culmination of 15 years of work by researchers led by Dr. Valentin Fuster, director of Mount Sinai Heart at Mount Sinai Hospital in New York City and general director of the National Center for Cardiovascular Research in Spain. 這研究是紐約市西奈山醫院西奈山心臟中心主任、西班牙國立心血管研究中心總監瓦倫丁．福斯特博士帶領研究人員研究15年的結晶。 “Combination pills are easier for the physician and for the patient, and the data are pretty clear — it translates into a benefit,” said Dr. Thomas J. Wang, chair of the department of internal medicine at UT Southwestern Medical Center, who was not involved in the research but wrote an editorial accompanying the study. 未參與研究但為研究報告撰寫社評的德州大學西南醫學中心內科系主任湯瑪斯．王博士說：「複方藥物對醫生和病患來說更簡便，數據非常清楚，它轉化為一種好處。」 The polypill combines a blood-pressure medication, a cholesterol-lowering drug and aspirin, which helps prevent blood clots. 這種複方製劑結合了降壓藥、降膽固醇藥和阿斯匹林，有助防止血栓。 The polypill used in the study has not been approved by the Food and Drug Administration and is not available to patients in the United States right now. Fuster said the results of the new trial would be submitted to the agency shortly in an effort to obtain approval. 這項研究使用的複方製劑還未獲得美國食品藥物管理局批准，目前在美國還不能給患者使用。福斯特 說，這項新試驗結果很快會提交給該機構，以爭取獲得批准。 And since participants became even more likely to keep taking the polypill over time, he said, “The potential results could be even better with more follow-up.” Several studies have shown that only about half of patients, or even less, take all their medications as instructed. 他說，由於參與者會逐漸的更可能繼續服用複方製劑，「若有更多後續研究，潛在結果可能更好」。數項研究顯示，只有大約一半甚至更少患者按照指示服用所有藥物。 The new study, a randomized controlled clinical trial, enrolled just under 2,500 patients at 113 sites in Spain, Italy, France, Germany, Poland, the Czech Republic and Hungary. 這項研究是一項隨機對照臨床試驗，在西班牙、義大利、法國、德國、波蘭、捷克和匈牙利的113個地點招募到近2500名患者。Source article: https://udn.com/news/story/6904/6601708 歡迎留言告訴我們你對這一集的想法： https://open.firstory.me/user/cl81kivnk00dn01wffhwxdg2s/comments Powered by Firstory Hosting

At the European Society for Medical Oncology Congress 2022, Dr. Rugo presented results from the TROPiCS-02 trial, which was looking to see if the targeted therapy Trodelvy could offer more benefits for people diagnosed with previously treated, metastatic, hormone receptor-positive, HER2-negative breast cancer than chemotherapy. Currently, Trodelvy is approved to treat previously-treated, metastatic triple-negative breast cancer. Listen to the episode to hear Dr. Rugo explain: the type of medicine Trodelvy is and how it works the results showing people diagnosed with previously treated, metastatic, hormone receptor-positive, HER2-negative breast cancer lived longer when they received Trodelvy compared to chemotherapy how the results from TROPiCS-02 fit into current treatment options

From the European Society for Clinical Virology 2022 Conference in Manchester UK, Vincent speaks with Emma Thomson about the recent outbreak of pediatric hepatitis of unknown etiology and the finding that it is linked to infection by adenovirus-associated virus 2. Hosts: Vincent Racaniello Guest: Emma Thomson Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Thomson laboratory Emma on TWiV 188 and TWiV 341 AAV2-associated pediatric hepatitis (bioRxiv) Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv

Scholars of German history, literature and cultural studies have created a long and rich scholarly tradition analysing the adoration of ‘nature' in German Romantic, nationalist, Heimat, youth, and Lebensreform movements. Political scientists have also produced a voluminous literature on the origins and significance of Germany's Green Party and the ‘post-material' values of the post-1968 generation. Germany is also well-known for its commitment to sustainable industrial development, as evidenced by one of Europe's best records in recycling, the regulation of industrial emissions and nature conservation. Yet ‘environmental history', at least this field as understood among its North American practitioners, has remained underdeveloped among German historians until very recently. Franz-Joseph Brüggemeier's pioneering studies of air and water pollution control in the Ruhr area were part of a growing interest in Umweltgeschichte in Germany during the 1980s and early 1990s, but these did not immediately spawn a new generation of imitators. German environmental history has begun to mature rapidly in the first decade of the twenty-first century, however, spurred on by Mark Cioc's The Rhine: An Ecobiography, which introduced readers to a new kind of ‘history from below' in which water, floodplains, forests and fish are active agents of political, economic and social transformation. David Blackbourn's prize-winning The Conquest of Nature, a magisterial survey of river canalization and wetland reclamation from Frederick the Great to the Federal Republic, stands out as one of the most influential books on German history published in 2006. It was the subject of a German Studies Association forum that engaged geographers, historians of technology and German historians in a fruitful conversation. The relationship between ecology, economy and culture remains at the centre of these and other new works, as well as contentious debates about the uncomfortable association between early twentieth-century nature conservation (Naturschutz) and National Socialist Blood and Soil policies, especially in occupied Poland during World War II. German History has invited five scholars to discuss the state of this new field: Dorothee Brantz (Centre for Metropolitan Studies, TU Berlin), Bernhard Gissibl (University of Mannheim), Paul Warde (University of East Anglia, UK), Verena Winiwarter (Klagenfurt University, IFF, Austria, and former President of the European Society for Environmental History), and Thomas Zeller (University of Maryland, USA). Thomas Lekan (University of South Carolina, USA) formulated the questions. --- Send in a voice message: https://anchor.fm/chrisabraham/message

Medical conferences often are a platform to showcase new clinical trophies. But that wasn't the case for Merck at this year's European Society for Medical Oncology meeting. The Big Pharma presented a series of trial flops for its megablockbuster cancer immunotherapy, Keytruda. We'll discuss if the Merck checkpoint inhibitor has reached a bottleneck or if it was just bad luck.  Also under discussion is the monkeypox test Emergency Use Authorization. Because monkeypox continues to spread in the U.S. and worldwide, the FDA granted its first EUA for a diagnostic test. This regulatory path was also used for COVID-19 tests. But the FDA learned a few lessons from the pandemic and hopes the new guidelines will help avoid the problems seen then.   To learn more about topics in this episode:  ESMO: AstraZeneca, Merck tout Lynparza's 'clinically meaningful' ovarian cancer survival edge but lose one in prostate cancer ESMO: Roche eyes untouched newly diagnosed lung cancer market for solo Tecentriq ESMO: Adding bempeg to Opdivo lowered response rate in Bristol Myers-Nektar failed cancer trial ESMO: GSK keeps the faith in anti-TIGIT plans; it's 'not always about being first' UPDATED ESMO: Amgen's Lumakras confirmatory lung cancer data leave door open for KRAS competitors ESMO: Gilead's Trodelvy makes surprise comeback with above-par breast cancer survival showing Here we go again: FDA opens up emergency authorizations to monkeypox tests Moderna sizes up private COVID vaccine market in US, where shots could cost $100 a pop Sony dives into nascent over-the-counter hearing aid market with WS Audiology partnership OTC birth control could be on the way from Perrigo, as FDA gathers expert panel Altimmune sees phase 1 success in tricky NASH indication with GLP-1 agonist Oramed phase 2 insulin drug data 'paint an exciting picture' in rocky NASH landscape Akero hits endpoints in midphase NASH trial, linking candidate to improvements in fibrosis BMS' preferred drug in its $74B Celgene buy is set to pay dividends, winning its first FDA nod The Top Line is produced by senior multimedia producer Teresa Carey with managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.See omnystudio.com/listener for privacy information.

The availability of a blood test for circulating DNA that can be used widely in healthy individuals to check for molecular signs of multiple cancers led Deb Schrag, MD, MPH, formerly of the Dana-Farber Cancer Center in Boston and currently Chair of the Department of Medicine at Memorial Sloan-Kettering Cancer Center, New York, to research it's use as a means of spotting a wide range of cancers early—including types for which there is currently no routine screening (Abstract 903O). At the European Society for Medical Oncology 2022 Annual Congress, she told OncTimes Talk reporter Peter Goodwin about the findings which give her confidence that widespread blood testing could play an important role in the overall battle against cancer.

En este episodio Edgardo Sobenes conversa con el Dr. Pau de Vílchez sobre los litigios climáticos. El Dr. de Vílchez inicia hablando sobre el estado actual de la producción de gases invernadero e identifica los grandes emisores por país y sector. Posteriormente nos comenta sobre las obligaciones de los países para reducir sus emisiones de gases invernadero bajo el Acuerdo de París y nos aclara los mecanismos de control, revisión y cumplimiento de obligaciones.  Aborda de forma detallada la competencia de cortes y tribunales nacionales, regionales e internacionales, e identifica los tres principales fundamentos que determinan la existencia de las obligaciones de los Estados, que son: el régimen jurídico internacional sobre el cambio climático, algunos principios del derecho ambiental internacional, y los derechos humanos. Finalmente elabora sobre la interacción y aplicación del derecho internacional del cambio climático por Cortes domésticas. Membresía del Podcast  https://www.hablemosdi.com/contenido-premium Acerca del Dr. Pau de Vílchez Moragues Libro Climate in Court: Defining State Obligations on Global Warming Through Domestic Climate Litigation Pau de Vílchez Moragues es Doctor cum laude en Derecho Internacional por la Universitat de les Illes Balears, licenciado en Derecho por la Universidad de Salamanca y máster en Relaciones Internacionales y Desarrollo por el Instituto de Estudios Políticos de París (Sciences-Po). Además, ha realizado numerosos cursos relacionados con el derecho de la Unión Europea y la cooperación al desarrollo y un año de estudios en la Universidad de Bolonia.  Es miembro de la Asociación Española de Profesores de Derecho Internacional y Relaciones Internacionales (AEPDIRI) y de la European Society of International Law (ESIL).Su experiencia laboral se ha desarrollado principalmente alrededor de tres ámbitos: los derechos humanos, la cooperación al desarrollo y el derecho del medio ambiente. Inició su actividad profesional con ACNUR en Egipto, Amnistía Internacional en Francia, y el Tribunal Penal Internacional para la ex-Yugoslavia en Holanda. Ha trabajado en proyectos de cooperación en Costa de Marfil y Níger, así como para la Agencia de Cooperación de las Illes Balears, ocupándose de las regiones Mediterránea, Oriente Próximo y Asia. Desde 2012 es profesor de Derecho Internacional Público en la UIB (actualmente como Profesor contratado doctor interino). Ha realizado estancias de investigación en la Universidad de Cambridge y la Universidad Rovira i Virgili, así como numerosas ponencias en congresos internacionales y estatales.Ha publicado numerosos artículos y capítulos de libro, así como informes científicos y artículos de prensa. Acaba de publicar el libro ‘Climate in Court. Defining State Obligations on Global Warming through Domestic Climate Litigation', con la editorial británica Edward Elgar. Desde 2021 es el Presidente del Comité de Expertos para la Transición Energética y el Cambio Climático de las Islas Baleares. En 2017 impulsó la creación del Laboratorio Interdisciplinario sobre Cambio Climático (LINCC) de la UIB, del cual es subdirector. Desde 2018 es el responsable en España del proyecto Clean Energy for EU Islands, de la Comisión Europea. Además, ha impulsado el ingreso de la UIB en la Convención Marco de Naciones Unidas sobre Cambio Climático (CMNUCC) y representa a la universidad en las Conferencias de las Partes (COP). En estos momentos, está preparando la realización de una asamblea ciudadana por el clima en las Islas Baleares.Adquiere aquí el libro " Hablemos de Derecho Internacional Volumen I" Support the show

Marco Santambrogio"Festival Filosofia"https://www.festivalfilosofia.it/Festival Filosofia, SassuoloDomenica 18 settembre 2022, ore 21:00Lezione Magistrale di Marco SantambrogioMeritoDare valore ai talentiIn quale modo difendere il programma meritocratico, con i suoi principi di distribuzione dei talenti, uguaglianza delle opportunità, riconoscimento dei meriti negli impieghi, anche attraverso una valorizzazione dell'istruzione come importante fattore di giustizia sociale?Marco Santambrogio ha insegnato Filosofia del Linguaggio presso l'Università di Parma e l'Università San Raffaele di Milano. È socio fondatore della European Society for Analytic Philosophy (ESAP) e della Società Italiana di Filosofia Analitica (SIFA). Le sue ricerche nell'ambito della filosofia analitica riguardano la filosofia del linguaggio, la semantica dei mondi possibili, il riferimento e la teoria della verità; si è occupato anche di filosofia morale e delle questioni del merito e delle uguali opportunità, collaborando con il “Forum della meritocrazia”. Ha scritto numerosi contributi per riviste scientifiche italiane e internazionali, come “The Journal of Philosophy”, “Nous”, “Synthese”, “Dialectica”. Tra le sue opere recenti: Forma e oggetto (Milano1992); Chi ha paura del numero chiuso? (Roma-Bari 1997); Manuale di scrittura non creativa (Roma-Bari 2006); Come si scrive un saggio (Roma-Bari 2015, ebook); Come si risponde a un'argomentazione (Roma-Bari 2015, ebook); Il complotto contro il merito (Roma-Bari 2022)Marco Santambrogio"Il complotto contro il merito"Laterza Editorihttps://www.laterza.it/È giusto che ciascuno abbia quello che merita; ingiusto che ottenga un bene, o soffra un male, che non merita. Questa è l'idea di giustizia di Aristotele e del senso comune. Michael Sandel obietta che la meritocrazia pretende di premiare il merito ma produce arroganza e umiliazione. L'accusa è infondata. A scuola, all'università, sul lavoro, nello sport non possiamo fare a meno di riconoscere e premiare il merito. La meritocrazia ha un volto umano.Si dice che in una società meritocratica i redditi seguano i meriti. Ma in alcune società contemporanee che si presentano come meritocratiche le differenze di reddito sono enormi. Com'è possibile che alcuni abbiano meriti superiori ad altri di centinaia di volte? Da qui prende oggi le mosse il rifiuto del programma meritocratico che nella seconda metà del secolo scorso era la sostanza del ‘sogno americano' ed era sottoscritto dal laburismo britannico e dal socialismo riformista europeo. Marco Santambrogio difende la meritocrazia con due ordini di argomenti. Dimostra da un lato che quelle società si presentano come meritocratiche ma non rispettano il principio irrinunciabile delle uguali opportunità. Dall'altro sostiene su solide basi filosofiche che il merito non si trasferisce dalle posizioni e dai posti di lavoro alle retribuzioni che li accompagnano. Non si butti dunque il bambino con l'acqua sporca. Si continui – o, in qualche caso, si cominci – a distribuire posti e posizioni rispettando le competenze, senza favoritismi e dando a tutti uguali opportunità. La meritocrazia consiste in questo. Quanto alle enormi differenze di reddito, si dimostri che sono meritate. Se non ci si riesce, una tassazione equa (richiesta dagli stessi principi meritocratici) si preoccuperà di ridurre le sperequazioni immeritate.IL POSTO DELLE PAROLEAscoltare fa Pensarehttps://ilpostodelleparole.it/

At the European Society for Medical Oncology Congress 2022, Dr. Naoto Ueno presented patient-reported quality-of-life outcomes from the DESTINY-Breast04 study, which found that compared to doctors' choice of chemotherapy, Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) improved both progression-free survival and overall survival in people diagnosed with previously treated metastatic HER2-low breast cancer. Listen to the episode to her Dr. Ueno explain: how the researchers assessed quality of life the results showing that Enhertu offered better quality of life than the doctors' choice of chemotherapy differences in side effects between Enhertu and chemotherapy

Biopharma executives and investors are bracing for the impact of the newly passed Inflation Reduction Act. On the latest BioCentury This Week podcast, BioCentury's editors discuss pharma CEOs' warnings that the law will reduce incentives for small molecule drug development, how biotech VCs may adjust deployment of their funds and how the government could implement the law.Turning to readouts from the European Society of Medical Oncology Congress, the BioCentury podcast team explains why the latest data for Amgen's Lumakras could shake up the KRAS inhibitor race and how Chinese investigator-initiated trials are accelerating CAR T innovation.

Hannah Wilkinson recently joined the University of Nottingham as Assistant Professor of Criminology and is a member of the Criminal Justice Research Centre. Prior to that, she was a Lecturer in Criminology at Keele University. Hannah's research interests lie in the areas of war, state crime and social harm. In particular, she is interested in the complex implications of 21st century conflict for former military personnel. You can find her most recent publication here https://t.co/haB3aOapDJ and you can see her talking at the Argentine Ambassador's residence this summer here https://www.academia.edu/video/l8bW8j Hannah completed her doctoral research under the supervision of Professor Ronnie Lippens, Dr. Evi Girling, and Dr. Samantha Weston at Keele University. The PhD thesis is entitled: ‘No Man's Land? Veterans' experiences of 21st century warfare and the return to post-conflict life'. Hannah uses in-depth qualitative and visual methodology, drawing theoretical inspiration from the works of Pierre Bourdieu on the (re)production of power and inequality within society, and from Zygmunt Bauman on the fluidity and precariousness of modern life.  She has worked with Staffordshire and Birmingham based charities to support criminalised veterans. This has involved sharing research findings and developing a training programme for practitioners. In addition, Hannah has worked as a Research Associate alongside Dr. Samantha Weston on projects with Re-Solv – around early intervention and prevention of volatile substance abuse, and with Staffordshire Police, evaluating the child sexual exploitation (CSE) prevention programme.  Hannah is a member of the European Society of Criminology, the British Society of Criminology, the Defence Research Network, and the European Group for the Study of Deviance and Social Control. Her current work explores the embodied traces of the ‘war on terror' and lived experience of austerity for former British military personnel. She is also working on an article that draws attention to the warning signs of fascism amid the UK government's response to Covid-19.

The largest cardiology meeting of the year worldwide is the European Society of Cardiology (ESC) meeting that was held in Barcelona, Spain. This week, Dr. Kahn discussed many large and important research studies of interest that were presented. Many were published online the same day of presentation, representing the newest information on heart disease diagnosis and care. Dr. Kahn recorded his p-cast while using his neuvanalife.com vagal nerve stimulator in his left ear and a discount code Kahn10 is available if you choose to use one too.

It's in the news! The top stories and headlines around the diabetes community this week include new progress in the quest for oral insulin to treat type 1, a new study says a common type 2 diabetes drug may help those with serious heart condition, a look at teen brains and T1D, NSAID and type 2 and more! Learn about the T1d Exchange: www.t1dexchange.org/stacey  Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! *Click here to learn more about OMNIPOD* *Click here to learn more about AFREZZA* *Click here to learn more about DEXCOM* Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines of the past seven days. XX In the news is brought to you by T1D Exchange! T1D Exchange is a nonprofit organization dedicated to improving outcomes for the entire T1D population. https://t1dexchange.org/stacey/ XX Our top story.. very early on here, but some progress in oral insulin for type 1. A team at University of British Columbia has developed a different kind of tablet that isn't made for swallowing, but instead dissolves when placed between the gum and cheek. This method delivered all the insulin to the liver without wasting or decomposing any insulin along the way. That's a big change from earlier studies and methods. The oral tablets absorb after about half an hour and last for up to four hours.. long way to go, no human trials yet. The the lead researcher on this project has a father with type 1 . https://www.sciencedaily.com/releases/2022/08/220830093215.htm?fbclid=IwAR1AzjI5UJma9I6g4hST044FS0MbJnUA0EXCmKXyhcOiOKL-ckIQTO4h8dY XX The type 2 diabetes drug dapagliflozin might also be used to help people with heart failure. A new study at Brigham and Women's Hospital showed that dapagliflozin – sold under the brand name Farxiga - reduced the risk of a cardiovascular death, or worsening heart failure, regardless of ejection fraction. Ejection fraction is a term that basically refers to how much blood is pumped out by the left ventricle of the heart each time it contracts. That's important because this drug has already been shown to help people who have the reduced pumping. And that's a lot more people. Big study here, more than 12-thousand people with lots of ages and races, benefits consistent throughout. https://www.bostonglobe.com/2022/08/29/business/brigham-womens-researchers-say-diabetes-drug-helps-reduce-heart-failure/ XX I hesitate to bring this study up, but it's gotten a lot of attention this week. It shows tight control of blood sugar in teens with Type 1 diabetes may help reduce the disease's damaging effects on the brain. But this small study from Nemours Children's Health, Jacksonville and Stanford University School of Medicine didn't release any numbers, n other words, it's not clear what they mean by tight control or at what level they're referring to for brain issues. Their findings to indicate that automated hybrid closed loop systems work really well and that better glucose control can actually improve brain structure and function in teens with type 1. I've reached out to this group and we're working on getting more information in a future episode. https://neurosciencenews.com/blood-sugar-brain-diabetes-21328/ XX Very early on here.. but an Indiana startup says they have a potentially game changing type 1 drug in development. In T1D, the body's immune system causes destruction of beta cells, and as a result, they eventually stop producing insulin. These researchers say their models show thy can take what were thought to be dead beta cells, which are actually sleeping beta cells, and increase their insulin secretion and, basically, get them back to a functional state.” They're focusing on a calcium imbalance within the beta cell and designing molecules to correct that calcium imbalance, ultimately returning the pancreas to a healthy state. JDRF has given them a big grant for a two year project, hopefully getting them to clinical trials. https://www.insideindianabusiness.com/articles/startup-awarded-nearly-1m-to-advance-diabetes-drug XX People with type 2 diabetes might face a substantially increased risk of heart failure if they take ibuprofen or some other type of nonsteroidal anti-inflammatory drug (NSAID), accord to a new Danish study. Short-term NSAID use increased risk of hospitalization for heart failure by 43% in people with type 2 but no previous heart problems. This was a large but preliminary study presented at the European Society of Cardiology's annual meeting. NSAIDs increased the risk of heart failure even more in type 2 diabetics who were 80 or older (78%) or who had high blood sugar levels (68%), the results showed. Those who'd never used an NSAID before had the worst reaction, with their heart failure risk nearly tripling. Type 2 diabetics should consult with their doctor before taking any pain medicine, the doctors said. Other types of pain meds -- specifically acetaminophen (Tylenol) -- should be safe for them to use. https://www.usnews.com/news/health-news/articles/2022-08-24/certain-painkillers-raise-heart-failure-risk-in-people-with-type-2-diabetes XX Back to the news in a moment but first.. The T1D Exchange Registry is a research study conducted online over time, designed to foster innovation and improve the lives of people with T1D. The platform is open to both adults and children with T1D living in the U.S. Personal information remains confidential and participation is fully voluntary. Once enrolled, participants will complete annual surveys and have the opportunity to sign up for other studies on specific topics related to T1D. The registry aims to improve knowledge of T1D, accelerate the discovery and development of new treatments and technologies, and generate evidence to support policy or insurance changes that help the T1D community. By sharing opinions, experiences and data, patients can help advance meaningful T1D treatment, care and policy. The registry is now available on the T1D Exchange website and is simple to navigate, mobile and user-friendly. For more information or to register, go to www.t1dregistry.org/stacey XX We told you about The Human Trial, Watch this gripping new documentary about the brave men and women who volunteer to test a radical new treatment for type 1 diabetes. n 2011, Lisa Hepner and her husband Guy Mossman heard about a radical stem cell treatment for diabetes, a disease that shockingly kills more than five million people each year. Driven by a desire to cure Lisa of her own type 1 diabetes (T1D), the filmmakers were given unprecedented, real-time access to a clinical trial — only the sixth-ever embryonic stem cell trial in the world. What follows is an intimate journey with the patients and scientists who put themselves on the line to be first. Now, in partnership with Beyond Type 1 & JDRF , they're offering the film for free. You are urged to make a donation to JDRF when you click over, there is an option to select zero, https://watch.showandtell.film/watch/the-human-trial-beyond-type-1 XX Next week we've got a great episode all about Omnipod 5 in the real world. I spoke to a panel of moms and a young adult using the system. And we've got Insulet's Director of Medical affairs addressing the questions that come up. This past episode is with my son Benny, talking about what it was like to spend 8 weeks away at non diabetes camp without any remote monitoring from us. Listen wherever you get your podcasts That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.

In this week's episode we dig into the microbiome with world renowned expert Dr. Ghannoum.  We chat about what the microbiome is, and that is not JUST bacteria.  How the microbiome not just in your gut, the health implications of these colonies, what disrupts them and what feeds them.   No one has done more research of the microbiome that Dr G., and he continues to research more everyday.Dr G is the Co-Founder and Chief Scientific Officer, BiohmHealthReceived an MSc in Medicinal Chemistry and his PhD in Microbial Physiology from the University of Technology in Loughborough, England, and an MBA from the Weatherhead School of Management at Case Western Reserve University, Cleveland, OH. A tenured Professor and Director of the Integrated Microbiome Core and Center for Medical Mycology, and Case Western Reserve University and University Hospitals Cleveland Medical Center. Published > 450 peer reviewed publication and 6 scientific books, and was on the top 1% of cited Scientists Worldwide Established a multidisciplinary Center of Excellence that combines basic and translational research that spans test tube to the bedside capabilities. He pioneered studies on the fungal communities residing in and on our body and coined the term ‘Mycobiome”. Awarded the Rhoda Benham Award from the MMSA, and the Freedom to Discover Award from Bristol-Myers Squibb for his outstanding and meritorious contributions to the fields of medical mycology and microbial biofilms. Fellow of the Infectious Disease Society of America (IDSA), past President of the Medical Mycological Society of the Americas (MMSA). Fellow of the American Academy of Microbiology (FAAM), and the European Society of Clinical  Microbiology and Infectious Diseases (FESCMID).An entrepreneur-scientist who has launched a number of companies focused on the treatment of biofilm infections, as well as microbial dysbiosis.

  Vidcast:  https://youtu.be/XVIrDcxqcms   When persons who survived a heart attack take a daily triple agent polypill, their risk of a second heart attack, stent placement or revascularization surgery, or stroke drops by 24% and their risk of death drops by 33%.  Cardiac researchers from New York's Mt. Sinai School of Medicine just reported these results in the New England Journal and presented them to the European Society of Cardiology after studying nearly 2500 patients ins 7 European countries.   This convenience polypill, marketed as Trinomia, contains low-dose aspirin to fight clotting and inflammation, ramipril to control blood pressure, and atorvastatin to normalize blood lipids.  These drugs are often prescribed separately, but other studies reveal fewer than 50% of patients take them faithfully.   That's why the polypill, a convenience med, works so much better.     https://www.nejm.org/doi/10.1056/NEJMoa2208275   #polypill #trinomia #heartattsack #mi #stroke #revascularization  

Early rhythm control in AF, treating coronary artery disease before transcatheter aortic valve implantation, and an ESC 2022 preview are the topics John Mandrola, MD, covers in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. Early Rhythm Control - Early AF Rhythm-Control Advantage Climbs With Comorbidity Burden: EAST-AFNET4 https://www.medscape.com/viewarticle/979627 - Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden https://www.ahajournals.org/doi/suppl/10.1161/CIRCULATIONAHA.122.060274 Early Rhythm-Control Therapy in Patients with Atrial Fibrillation https://www.nejm.org/doi/full/10.1056/NEJMoa2019422 II. CAD and Aortic Stenosis - No Survival Gains Seen From Pre-TAVR PCI of Complex CAD https://www.medscape.com/viewarticle/979408 - The Effect of Coronary Lesion Complexity and Preprocedural Revascularization on 5-Year Outcomes After TAVR https://doi.org/10.1016/j.jcin.2022.06.019 - Transcatheter Aortic Valve Implantation With or Without Percutaneous Coronary Artery Revascularization Strategy: A Systematic Review and Meta‐Analysis https://www.ahajournals.org/doi/10.1161/JAHA.117.005960 - ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic Valve implantaTION): A Randomized Clinical Trial https://www.jacc.org/doi/full/10.1016/j.jcin.2021.06.041 III. ESC Trials - Mandrola Previews His Top 5 Trials From ESC 2022 https://www.medscape.com/viewarticle/979560 TIME - Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension https://pubmed.ncbi.nlm.nih.gov/35983870/ - Empirical Evaluation of Very Large Treatment Effects of Medical Interventions https://jamanetwork.com/journals/jama/fullarticle/1386610 SECURE - Polypill Strategy in Secondary Cardiovascular Prevention http://www.nejm.org/doi/full/10.1056/NEJMoa2208275

In this week's View, Dr. Eagle discusses the comparative risks of initial aortic events associated with genetic thoracic aortic disease, then looks at the harmonization of the American College of Cardiology/American Heart Association's and the European Society of Cardiology/European Society of Hypertension's Guidelines on blood pressure and hypertension. Finally, Dr. Eagle examines a study looking at how polygenic risk score may predict sudden death in patients with coronary disease and preserved systolic function.

Neste episódio do Podcast CRUZAMENTO, André Correia e Daniel Guedelha conversam com Pedro Gouveia sobre oncologia, filantropia e, de como será o futuro com a existência da 5ª dimensão trazida pelo metaverso e a holomedicina. Falaram também sobre a sustentabilidade dentro da Fundação Champalimaud. Pedro Gouveia, MD, PhD, graduated in Medicine in 2004 at NOVA Medical School | Faculdade de Ciências Médicas (NMS|FCM), Portugal. He completed his General Surgery residency program in 2013 at Hospital de Matosinhos, after an Oncoplastic Breast Surgery Fellowship at the Paris Breast Center (2012/2013). During his residency program he has successfully designed and implemented a Walking Clinic and a Fast Track program applied for upper GI and colorectal surgery. He is a board certified breast surgeon by the European Society of Surgical Oncology since 2015. In 2021 he has received a PhD degree at Lisbon Medical School with the theme: 3D Digital Breast Cancer Surgery with Augmented Reality. Pedro is a dedicated breast specialist, designer and researcher at the Breast Unit of Champalimaud Foundation, Lisbon, Portugal since 2013. Pedro is also the Oncoplastic Breast Consortium Coordinator for Portugal since 2019 and member of the Senology Portuguese Society since 2017. He was recently selected to be a member of the European Society of Surgical Oncology Education and Training Committee (position will start at October 2022). He has authored and co-authored several papers on international journals and authored two book chapters. He has also authored several communications in medical and technological conferences. He is Associate Editor of Clinical Surgical Oncology journal since 2022. He is reviewer for The Breast Journal and World Journal of Surgery. Pedro's research interests include breast cancer, oncoplastic breast surgery, breast reconstruction, 3D breast modeling, surgical breast simulation, augmented reality, connected care/health, big data, artificial intelligence and 5G network with edge computing. Pedro actively participated in European and National research projects: Assistant researcher of the Picture Project, an FP7 EU (grant number: 600948) funded consortium between 2013 and 2016. Overall budget € 3 218 224. The PICTURE project aims to address this issue by providing objective tools to predict the aesthetic outcome of breast conserving surgery; BCCT.plan consortium as chief medical scientist, a PT2020 funded project (NORTE-01-0247-FEDER-017688) between 2016 and 2020. Overall budget € 532 516. It aimed to create a novel simulation and treatment planning environment between radiological diagnosis and surgical cancer therapy, including an objective tool to predict the aesthetic outcome of breast cancer conservative treatment; Principal investigator of the MetaBreast project, a proof-of-concept trial that aims to investigate a new digital and non-invasive method for intraoperative localization of non-palpable lesions using artificial intelligence and augmented reality - Breast 4.0. The first successful surgery took place at the Breast Unit, Champalimaud Clinical Centre - January 23, 2020. With this project Pedro won the Best and Greatest in Portuguese Technology - Innovation category and Honorable Mention at Prémio Banco Carregosa 2022. Contactos: CruzamentoPodcast.comcruzamentopodcast@gmail.comLinkedIN: CruzamentoTwitter: @cruzamentofmFacebook: @podcastcruzamentoYouTube: Podcast Cruzamento

Today my guest is Dr Martin Weihrauch What we discuss with Dr Weihrauch: How he became interested in computers and computer programming Why he decided to go to medical school and how he became interested in hematology and oncology The origin of Smart In Media How Smart In Media became involved with the European Society of Pathology and the International Academy of Pathology How Smart In Media branched out from education into diagnostics How Smart In Media integrates AI and Dr Weihrauch's thoughts on the future of AI What is on the horizon for Smart In Media Links for this episode: Health Podcast Network  LabVine Learning Doctors on Social Media Laboratory Transformation Seasonal School  The ConfLab from LabVine Dress A Med scrubs pathCast - Key Concepts In Specimen Grossing   Smart In Media website Dr Weihrauch on the Digital Pathology Podcast European Society of Pathology International Academy of Pathology   People of Pathology Podcast: Website Twitter

Today my guest is Pathologist Dr Fatima Carneiro What we discuss with Dr Carneiro: How her interest in pediatrics changed to pathology Her education in Angola, and some of her experiences there How she became interested in teaching How she started working on research in gastric cancer, and specifically hereditary gastric cancer Her experience as an editor for The WHO Blue Book on Tumors of the Digestive System How she became involved with the European Society of Pathology, and some of her accomplishments as President of the Society How she established a national tumor bank network in Portugal Why international efforts are important in pathology The state of pathology recruitment in Portugal Links for this episode: Health Podcast Network  LabVine Learning Doctors on Social Media LabVine Laboratory Transformation Seasonal School The ConfLab from LabVine Dress A Med scrubs   Dr Fatima Carneiro on Wikipedia The Pathologist Power List 2018 The 2019 WHO Classification of Tumors of the Digestive System Pathological Society of GB and Ireland Grand Rounds May 2022   People of Pathology Podcast: Website Twitter

Today my guest is Pathologist Dr Fred Bosman What we discuss with Dr Bosman: How he went from being interested in surgery to pathology His PhD in cytogenetics and why he chose to pursue this degree His experience early in his career at the University of Surinam Some other countries where he has worked, and his experiences there How he came to specialize in GI pathology How his research combines experimental and diagnostic pathology Why he thinks it is essential for the younger generation of pathologists to be educated in molecular pathology How he got involved with the European Society of Pathology and his term as president of the Society Why he believes that pathology is a dynamic field Links for this episode: Health Podcast Network  LabVine Learning Doctors on Social Media Laboratory Transformation Seasonal School From Labvine The ConfLab from LabVine Dress A Med scrubs   Dr Fred Bosman Wikipedia page The Pathologist Power List 2015 Prof. Fred Bosman Talks about his #6 ranking in The Power List and His Passion for Pathology   People of Pathology Podcast: Website Twitter

In this episode, hosts Dr. Peter Lu and Dr. Jason Silverman talk to Dr. Rachel Rosen about one of the most common problems we see as pediatric gastroenterologists (or as pediatricians): gastroesophageal reflux disease or GERD. She explains how she approaches the evaluation and management of babies who spit up frequently and why all that spits up is not GERD. We also talk about the care of older children and adolescents who have GERD, including those with GERD symptoms that persist despite a trial of acid suppression. She discusses the value of pH-impedance testing and also explains why she is cautious about recommending anti-reflux surgery.Dr. Rosen is a pediatric gastroenterologist at Boston Children's Hospital, Director of their Aerodigestive Center, and an Associate Professor at Harvard Medical School. She is also the first author of the 2018 NASPGHAN and ESPGHAN guidelines on the evaluation and management of children with GERD.Learning Objectives:1) Recognize the evolving definition of GERD in children.2) Understand the pathophysiology and management of GERD symptoms in infants.3) Understand the role of pH-impedance testing in the evaluation of children with GERD symptoms.4) Understand the role of anti-reflux surgery in the management of children with severe GERD.CME for NASPGHAN members is available here!Links:Rosen R, et al. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology,Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018.As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Produced by: Peter LuSupport the show

This episode discusses things to consider beyond the severity when assessing aortic regurgitation using echocardiography. It includes references to ASE, EACVI, ESC and ACC guidelines.An echo education podcast.References referred to in the episode:1.      Lancellotti, P. et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. European Heart Journal - Cardiovascular Imaging. 2013; 14(7):–644, https://doi.org/10.1093/ehjci/jet1052.      Zoghbi et al. Recommendations for the Noninvasive Evaluation of Native Valvular Regurgitation. Journal of the American Society of Echocardiography. 2017; 30(4):303-371. https://www.onlinejase.com/article/S0894-7317(17)30007-X/fulltext3.       Vahanian, A. et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2021 https://doi.org/10.1093/eurheartj/ehab3954.       Otto, C. et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021; 143:e72-e227. https://doi.org/10.1161/CIR.0000000000000923

On today’s show I have Lauren Finnerty, a nurse practicer at Victory Men’s Health here to discuss yet another misconception of testosterone therapy and that is the thought that testosterone can cause “thick blood” which can in turn cause a heart attack, stroke or blood clot. This is misinformation. Evidence shows the link between testosterone replacement therapy and the increase of hematocrit doesn’t lead to more cardiac or thrombotic events in men. If you have been told this by a medical provider there is confusion around the difference between erythrocytosis and polycythemia vera. The two conditions are completely different but many medical providers don’t know that increased levels of hematocrit and hemoglobin (blood counts) from testosterone (secondary erythrocytosis) doesn’t cause the same medical issues as polycythemia vera. This misunderstanding could lead to medical providers taking patients off of their testosterone or cause them to over phlebotomize the patient that could cause the patient to become iron deficient or anemic. Today we want to arm you with the facts! Studies To Support Today's Conversations: Adverse effects of testosterone replacement therapy: an update on the evidence and controversy Hemoglobin and testosterone: importance on high altitude acclimatization and adaptation Blood doping and its detection AUA: Testosterone may not deserve its reputation as a cardiovascular culprit Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions A Psychosocial Approach to Erectile Dysfunction: Position Statements from the European Society of Sexual Medicine (ESSM) Dr. Eric and Neal Rouzier, MD discuss all things related to hormone optimization! Episode 5 Hormonal Health with Dr. Neal Rouzier (Part 1) is an introduction to the concepts that everyday people need to know and understand regarding the critical role hormones play in our optimal health. Email me at podcast@amystuttle.com Victory Men's Health

"We listen a lot to our customers and their patients" This piece came shortly after GE Healthcare's Portrait Mobile product launch, live from the European Society of Anaesthesiology and Intensive Care (ESAIC). Presented by Desiree Chappell and Sol Aronson with their guests Tom Westrick, President & Chief Executive Officer of Life Care Solutions at GE Healthcare and Brandon Henak, Global Marketing Director, Monitoring Solutions at GE Healthcare. -- Get all the headlines and information about the hot topics and major events of this conference exclusively from TopMedTalk, thanks to our partners in GE Healthcare. Go now to www.twitter.com/topmedtalk Go now to https://www.youtube.com/channel/UC-HYQmeIwcFCYO1hoQ8jShQ Go now to https://www.facebook.com/TopMedTalk1 Go now to https://www.linkedin.com/company/topmedtalk/ Find out more about The ESAIC here: https://www.esaic.org/ Find out more about GE Healthcare here: https://www.gehealthcare.com/

"Most non clinicians.. think the most risky time when you're having surgery is when you're having surgery. That is categorically false; the most risky time is after surgery!" This piece came shortly after GE Healthcare's Portrait Mobile product launch, live from the European Society of Anaesthesiology and Intensive Care (ESAIC). Presented by Desiree Chappell and Sol Aronson with their guests Neal Sandy, General Manager, Monitoring Solutions at GE Healthcare and Karla Asikainen, Senior Global Product Manager, Mobile Digital Health at GE Healthcare. -- Get all the headlines and information about the hot topics and major events of this conference exclusively from TopMedTalk, thanks to our partners in GE Healthcare. Go now to www.twitter.com/topmedtalk Go now to https://www.youtube.com/channel/UC-HYQmeIwcFCYO1hoQ8jShQ Go now to https://www.facebook.com/TopMedTalk1 Go now to https://www.linkedin.com/company/topmedtalk/ Find out more about The ESAIC here: https://www.esaic.org/ Find out more about GE Healthcare here: https://www.gehealthcare.com/

We welcome YOU back to America's leading higher education podcast, The EdUp Experience! It's YOUR time to #EdUp In this episode, YOUR guest is Dr. Fernando Galvan, Secretary General at the International Association of University Presidents (IAUP), & Former President of Universidad de Alcala in Madrid, Spain, YOUR guest cohost is Dr. Vistasp Karbhari, Professor at Department of Mechanical & Aerospace Engineering at The University of Texas at Arlington, YOUR host is Dr. Joe Sallustio, & YOUR sponsor is Fierce Education! Do YOU know the percentage of funds that most colleges in Europe receive from public sources compared to US institutions? Ready to get YOUR mind blown? Listen in to #EdUp! Dr. Fernando Galvan is member of the editorial boards of more than 20 international scholarly journals in English studies, & has supervised 24 PhD dissertations in that field in the period 1988–2012. He was visiting scholar in the Department of Comparative Literature of Harvard University in 1993 & 1994. He was appointed in 1994 member of the International Association of University Professors of English (IAUPE), & in 2003 corresponding fellow (FEA) of The English Association, in the UK. During the academic year 2009–2010 he was associate member of the Faculty of English at the University of Oxford, & in October 2009 was appointed visiting fellow of Corpus Christi College, Oxford. He has held numerous relevant academic positions in Spain & internationally: as member of the boards of the European Association for American Studies (EAAS, 1993–1999), & of the Spanish Society for General & Comparative Literature (SELGYC, 1995–2006); president of the Spanish Association of Anglo-American Studies (AEDEAN, 1996–2002), & president of the European Society for the Study of English (ESSE, 2007–2013) Thank YOU so much for tuning in. Join us on the next episode for YOUR time to EdUp! Connect with YOUR EdUp Team - Elvin Freytes & Dr. Joe Sallustio ● Join YOUR EdUp community at The EdUp Experience! We make education YOUR business! --- Send in a voice message: https://anchor.fm/edup/message

In this episode of EMplify: Conversation, Sam Ashoo, MD and TR Eckler, MD discuss high sensitivity troponin testing and clinical pathways.Topics discussed include: Which troponin assay are you currently using and what are its limits of detection? Do delta troponin results only count if they increase? If the test result is indeterminate, then what? repeat in 1 hr (European standard), repeat in 3 hours (depending on chest pain onset), or just admit if the HEAR(T) score is high? What does one negative troponin on presentation mean? No death in 30 days to 1 year but still missed MI?And more... ReferencesAnand A, et al; HiSTORIC Investigators†. High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial. Circulation. 2021 Jun 8;143(23):2214-2224. doi: 10.1161/CIRCULATIONAHA.120.052380. Epub 2021 Mar 23. PMID: 33752439; PMCID: PMC8177493.Chapman AR, et al. Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome. JAMA. 2017 Nov 21;318(19):1913-1924. doi: 10.1001/jama.2017.17488. Erratum in: JAMA. 2018 Mar 20;319(11):1168. Soerensen NA [corrected to Sorensen NA]. PMID: 29127948; PMCID: PMC5710293.Chenevier-Gobeaux C, et al. Multi-centre evaluation of recent troponin assays for the diagnosis of NSTEMI. Pract Lab Med. 2018 Feb 26;11:23-32. doi: 10.1016/j.plabm.2018.02.003. PMID: 30014015; PMCID: PMC6045566.Chiang CH, Chiang CH, Lee GH, Qian F, Chen SC, Lee CC. Time to Implement the European Society of Cardiology 0/1-Hour Algorithm. Ann Emerg Med. 2020 Nov;76(5):690-692. doi: 10.1016/j.annemergmed.2020.05.038. PMID: 33097132; PMCID: PMC7575504.McCarthy CP, Januzzi JL Jr. Increasingly Sensitive Troponin Assays: Is Perfect the Enemy of Good? J Am Heart Assoc. 2020 Dec;9(23):e019678. doi: 10.1161/JAHA.120.019678. Epub 2020 Nov 26. PMID: 33238785; PMCID: PMC7763764.Neumann JT, et al. Application of High-Sensitivity Troponin in Suspected Myocardial Infarction. N Engl J Med. 2019 Jun 27;380(26):2529-2540. doi: 10.1056/NEJMoa1803377. PMID: 31242362.Miller J, Cook B, Singh-Kucukarslan G, Tang A, Danagoulian S, Heath G, Khalifa Z, Levy P, Mahler SA, Mills N, McCord J. RACE-IT - Rapid Acute Coronary Syndrome Exclusion using the Beckman Coulter Access high-sensitivity cardiac troponin I: A stepped-wedge cluster randomized trial. Contemp Clin Trials Commun. 2021 Apr 23;22:100773. doi: 10.1016/j.conctc.2021.100773. PMID: 34013092; PMCID: PMC8114080.

ABOUT TODAY's EPISODE Today we look at everything from polypodium leucotomos to UPF rated clothing. What else is out there for besides sunscreen for sun protection? Enjoy the episode! SUPPORT! Thank you SO much for your constant support. It means the world to me. If you are wondering how you can support, please see below Share share share to the ends of the world: You can share this podcast to as many people as you know and love. You does not love a fun podcast about hair and skin? See links for that here https://linktr.ee/ChiomaAgha Support financially: https://anchor.fm/chioma-agha Download: Do you know that you can download any episode? Take me (well my voice, LOL) anywhere you are. Just click on download, and voila! Listen: Errmmm listen listen and listen again. You can listen one zillion uncountable billion times. LOL. Listen to the Ads ooooooo. T for Tenks REFERENCES 1. 1. Serpone, Nick. “Sunscreens and their usefulness: have we made any progress in the last two decades?.” Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology vol. 20,2 (2021): 189-244. doi:10.1007/s43630-021-00013-1 2. 1. Katja Žmitek, Janko Žmitek, Mirjam Rogl Butina, Hristo Hristov, Tina Pogačnik, Igor Pravst, Lee, Erica H et al. “Dietary lutein reduces ultraviolet radiation-induced inflammation and immunosuppression.” The Journal of investigative dermatology vol. 122,2 (2004): 510-7. doi:10.1046/j.0022-202X.2004.22227. 3. Christophe Antille, Christian Tran, Olivier Sorg, Pierre Carraux, Liliane Didierjean, Jean-Hilaire Saurat. "Vitamin A Exerts a Photoprotective Action in Skin by Absorbing Ultraviolet B Radiation". Journal of Investigative Dermatology, Volume 121, Issue 5, 2003, Pages 1163-1167,ISSN 0022-202X. doi.org/10.1046/j.1523-1747.2003.12519. 4. Caccialanza, M et al. “Oral polypodium leucotomos extract photoprotective activity in 57 patients with idiopathic photodermatoses.” Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia vol. 146,2 (2011): 85-7. 5. Berman, Brian et al. “Polypodium Leucotomos--An Overview of Basic Investigative Findings.” Journal of drugs in dermatology : JDD vol. 15,2 (2016): 224-8. 6. Dietary lutein supplementation protects against ultraviolet-radiation-induced erythema: Results of a randomized double-blind placebo-controlled study. Journal of Functional Foods. Volume 75, 2020, 104265, ISSN 1756-4646. Disclaimer The information provided on this podcast, including but not limited to, text, graphics, are for informational purposes only and does not serve as a diagnosis, treatment or substitute for medical advice. Always seek the advice of a qualified health care professional for any medical condition you may be experiencing. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/chioma-agha/support

This is another episode in our AI is Here series, and today, we're focusing on AI in the hospital setting. In this episode, we discuss patient data and being able to guide a patient's treatment journey with artificial intelligence. Our guest is Dr. Kostas Papagiannopoulos. Kostas is an Honorary Senior Lecturer at Leeds University and serves as Thoracic Surgeon for Leeds Teaching Hospitals. He is also a Medical Advisor to several substantial medical device companies and, until recently, was President of the European Society for Thoracic Surgeons. In today's episode, Kostas discusses where he's seeing AI make its way into the hospital setting and some of the critical barriers to adoption, and how leaders should overcome them. This series is brought you to by SambaNova Systems. SambaNova believes that AI is here, and we've partnered with them to bring you leading experts across industries to discuss where AI is making an impact today.

ABOUT TODAY's EPISODE How you like the title, huh? Oscars loading... Hi guys! In today's episode, we look at ways we can protect ourselves from harmful UV rays. Did you know you can use other things beside sunscreen? Well the tea is waiting for you in this episode. I hope you enjoy! SUPPORT! Thank you SO much for your constant support. It means the world to me. If you are wondering how you can support, please see below Share share share to the ends of the world: You can share this podcast to as many people as you know and love. You does not love a fun podcast about hair and skin? See links for that here https://linktr.ee/ChiomaAgha Support financially: https://anchor.fm/chioma-agha Download: Do you know that you can download any episode? Take me (well my voice, LOL) anywhere you are. Just click on download, and voila! Listen: Errmmm listen listen and listen again. You can listen one zillion uncountable billion times. LOL. Listen to the Ads ooooooo. T for Tenks REFERENCES 1. 1. Serpone, Nick. “Sunscreens and their usefulness: have we made any progress in the last two decades?.” Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology vol. 20,2 (2021): 189-244. doi:10.1007/s43630-021-00013-1 2. 1. Katja Žmitek, Janko Žmitek, Mirjam Rogl Butina, Hristo Hristov, Tina Pogačnik, Igor Pravst, Lee, Erica H et al. “Dietary lutein reduces ultraviolet radiation-induced inflammation and immunosuppression.” The Journal of investigative dermatology vol. 122,2 (2004): 510-7. doi:10.1046/j.0022-202X.2004.22227. 3. Christophe Antille, Christian Tran, Olivier Sorg, Pierre Carraux, Liliane Didierjean, Jean-Hilaire Saurat. "Vitamin A Exerts a Photoprotective Action in Skin by Absorbing Ultraviolet B Radiation". Journal of Investigative Dermatology, Volume 121, Issue 5, 2003, Pages 1163-1167,ISSN 0022-202X. doi.org/10.1046/j.1523-1747.2003.12519. Disclaimer The information provided on this podcast, including but not limited to, text, graphics, are for informational purposes only and does not serve as a diagnosis, treatment or substitute for medical advice. Always seek the advice of a qualified health care professional for any medical condition you may be experiencing. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/chioma-agha/support